CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-3 OR MESOTHELIN Read more about CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-3 OR MESOTHELIN US Patent 11,802,163Filed on 2020-05-07
CHIMERIC ANTIGEN RECEPTORS TARGETING TUMOR ANTIGENS Read more about CHIMERIC ANTIGEN RECEPTORS TARGETING TUMOR ANTIGENS South Korea10-2020-7014565Filed on 2018-11-07
CHIMERIC ANTIGEN RECEPTORS TARGETING TUMOR ANTIGENS Read more about CHIMERIC ANTIGEN RECEPTORS TARGETING TUMOR ANTIGENS European Patent18822526.2Filed on 2018-11-07
CHIMERIC ANTIGEN RECEPTORS TARGETING TUMOR ANTIGENS Read more about CHIMERIC ANTIGEN RECEPTORS TARGETING TUMOR ANTIGENS China201880073043.9Filed on 2018-11-07
Compositions and Methods for Treating Cancer with Anti-ROR1 Immunotherapy Read more about Compositions and Methods for Treating Cancer with Anti-ROR1 Immunotherapy US Patent 11,453,719Filed on 2019-09-30
Fully Human Antibody Targeting Human CD123 For Cancer Threpeutics Development Read more about Fully Human Antibody Targeting Human CD123 For Cancer Threpeutics Development US Application 16/578,063Filed on 2019-09-20
COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ANTI-CD123 IMMUNOTHERAPY Read more about COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ANTI-CD123 IMMUNOTHERAPY Patent Cooperation TreatyPCT/US2019/052226Filed on 2019-09-20
PEPTIDE HYDROGELS AND USE THEREOF Read more about PEPTIDE HYDROGELS AND USE THEREOF US Patent 11,661,439Filed on 2020-06-16
M971 CHIMERIC ANTIGEN RECEPTORS Read more about M971 CHIMERIC ANTIGEN RECEPTORS US Patent 11,807,682Filed on 2020-05-08
T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 Read more about T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 Israel274003Filed on 2020-04-16